• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·TATVA.NS
Share

Tatva Chintan Pharma Chem Limited Stocks

₹ 1412.1Last Updated 14.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 325.50M

₹ 1412.1
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tatva Chintan Pharma Chem Limited, an Indian-based enterprise, specializes in the production and distribution of diverse specialty chemicals. Its extensive product range encompasses essential components like structure-directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts vital for supercapacitor batteries. Furthermore, the company supplies pharmaceutical active pharmaceutical ingredients (APIs), agrochemical formulations, and various other specialized chemical products, including intermediates, disinfectants, catalytic agents, and solvents. Beyond manufacturing, Tatva Chintan engages in the trading of specialty chemicals and offers quaternary compounds (quats) and bulk drug substances. The firm's clientele spans a broad spectrum of sectors, such as the automotive, petrochemical, pharmaceutical, agricultural chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance industries. Its global reach extends to approximately 25 nations, where its products are exported. Established in 1996, Tatva Chintan Pharma Chem Limited maintains its corporate headquarters in Vadodara, India.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of TATVA.NS is 1480 and suggests 6.35% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommend

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.07.2026 19:54

Sales at Cartier's parent company were twice as strong as expected. This bolstered the luxury market

15.07.2026 19:06

Oppenheimer withdrew its recommendation to buy IBM stock following its historic plunge

15.07.2026 18:44

Kaspi.kz has completed the acquisition of Turkey's Rabobank

15.07.2026 18:25

Chip test maker Aehr extending gains after earnings and revenue beats, upbeat outlook

15.07.2026 18:04

Wholesale prices in the U.S. fell in June—a development the market did not expect

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026